Eric Mangin

935 total citations
28 papers, 757 citations indexed

About

Eric Mangin is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Eric Mangin has authored 28 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Epidemiology. Recurrent topics in Eric Mangin's work include Antifungal resistance and susceptibility (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Eric Mangin is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Eric Mangin collaborates with scholars based in United States, Germany and United Kingdom. Eric Mangin's co-authors include Marian Iwamoto, Larissa Wenning, Keith Gottesdiener, John A. Wagner, Julie A. Stone, Jeffrey Chodakewitz, William D. Hanley, Amelia S. Petry, Kalyan Ghosh and Ka Lai Yee and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Eric Mangin

27 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Mangin United States	14	358	234	170	163	162	28	757
Paolo Baroldi Italy	12	353 1.0×	55 0.2×	29 0.2×	22 0.1×	21 0.1×	23	733
Antoine Tarral France	14	66 0.2×	204 0.9×	60 0.4×	43 0.3×	169 1.0×	29	560
Yahong Peng United States	15	133 0.4×	407 1.7×	26 0.2×	5 0.0×	80 0.5×	34	815
Diane Kleinermans United Kingdom	11	650 1.8×	398 1.7×	24 0.1×	2 0.0×	203 1.3×	15	972
Daniel Pearce United States	10	378 1.1×	347 1.5×	13 0.1×	5 0.0×	72 0.4×	17	698
Audrey Boulaméry France	12	245 0.7×	131 0.6×	24 0.1×	5 0.0×	282 1.7×	31	582
Anna Maria Spera Italy	9	66 0.2×	92 0.4×	36 0.2×	23 0.1×	8 0.0×	20	224
Bregt S Kappelhoff Netherlands	11	530 1.5×	124 0.5×	20 0.1×	22 0.1×	34 0.2×	21	693
Abhijeet Singh India	10	223 0.6×	105 0.4×	6 0.0×	14 0.1×	25 0.2×	26	428
Annika Gorenz United States	6	160 0.4×	67 0.3×	10 0.1×	35 0.2×	4 0.0×	6	475

Countries citing papers authored by Eric Mangin

Since Specialization

Citations

This map shows the geographic impact of Eric Mangin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Mangin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Mangin more than expected).

Fields of papers citing papers by Eric Mangin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Mangin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Mangin. The network helps show where Eric Mangin may publish in the future.

Co-authorship network of co-authors of Eric Mangin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Mangin. A scholar is included among the top collaborators of Eric Mangin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Mangin. Eric Mangin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winchell, Gregory A., Rik de Greef, Rebecca E. Wrishko, et al.. (2024). A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia. Antimicrobial Agents and Chemotherapy. 68(4). e0119723–e0119723. 3 indexed citations

Li, Xiaodong, et al.. (2021). Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning. Journal of Clinical Psychopharmacology. 41(4). 414–420. 9 indexed citations

Liu, Kai‐Yan, Depei Wu, Junmin Li, et al.. (2020). Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection. Advances in Therapy. 37(5). 2493–2506. 5 indexed citations

Groll, Andreas H., Hisham Abdel‐Azim, Thomas Lehrnbecher, et al.. (2020). Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial. International Journal of Antimicrobial Agents. 56(3). 106084–106084. 32 indexed citations

Arrieta, Antonio, Lillian Sung, John S. Bradley, et al.. (2019). A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. PLoS ONE. 14(3). e0212837–e0212837. 34 indexed citations

Wrishko, Rebecca E., Jacqueline B. McCrea, Ka Lai Yee, et al.. (2019). Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects. Clinical Drug Investigation. 39(5). 441–451. 15 indexed citations

Chen, Xia, Ji Jiang, Pei Hu, et al.. (2018). Odanacatib Pharmacokinetics Comparison Between Chinese and Non‐Chinese Postmenopausal Women. Clinical Pharmacology in Drug Development. 7(7). 744–750. 4 indexed citations

Feng, Hwa-ping, Zifang Guo, Lisa Ross, et al.. (2018). Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. Journal of Antimicrobial Chemotherapy. 74(3). 710–717. 4 indexed citations

Rizk, Matthew L., Elizabeth G. Rhee, Patricia Jumes, et al.. (2018). Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 62(3). 66 indexed citations

10.

Marshall, William L., Hwa-ping Feng, Luzelena Caro, et al.. (2017). No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel. European Journal of Clinical Pharmacology. 73(5). 593–600. 7 indexed citations

11.

Greef, Rik de, et al.. (2016). Immunogenicity of pembrolizumab (pembro) in patients (pts) with advanced melanoma (MEL) and non-small cell lung cancer (NSCLC): Pooled results from KEYNOTE-001, 002, 006, and 010.. Journal of Clinical Oncology. 34(15_suppl). 3063–3063. 10 indexed citations

12.

Breidinger, Sheila, Richard C. Simpson, Eric Mangin, & Eric Woolf. (2015). Determination of suvorexant in human plasma using 96-well liquid–liquid extraction and HPLC with tandem mass spectrometric detection. Journal of Chromatography B. 1002. 254–259. 19 indexed citations

13.

Sun, Hong, Ka Lai Yee, Sean E. Gill, et al.. (2015). Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects. Journal of Psychopharmacology. 29(11). 1159–1169. 18 indexed citations

14.

Mavridou, Eleftheria, et al.. (2014). Pharmacodynamics of Imipenem in Combination with β-Lactamase Inhibitor MK7655 in a Murine Thigh Model. Antimicrobial Agents and Chemotherapy. 59(2). 790–795. 43 indexed citations

15.

Mangin, Eric, Wendy W. Yeh, Luzelena Caro, et al.. (2013). Safety and pharmacokinetics of single and multiple oral doses of MK-8742, an HCV NS5A inhibitor, in healthy subjects. Ghent University Academic Bibliography (Ghent University). 3 indexed citations

16.

Sun, Hong, William P. Kennedy, Darren Wilbraham, et al.. (2013). Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men. SLEEP. 36(2). 259–67. 132 indexed citations

17.

Mangin, Eric. (2009). Maître Eckhart et l'expérience du détachement. Études. Tome 411(7). 65–76. 1 indexed citations

18.

Hanley, William D., Larissa Wenning, James Kost, et al.. (2009). Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir. Antimicrobial Agents and Chemotherapy. 53(7). 2752–2755. 35 indexed citations

19.

Iwamoto, Marian, Kelem Kassahun, Matthew D. Troyer, et al.. (2007). Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation. The Journal of Clinical Pharmacology. 48(2). 209–214. 70 indexed citations

20.

Mangin, Eric. (2001). B. Beyer de Ryke, Maître Eckhart. Une mystique du détachement, Coll. « Figures illustres », 2000. Revue des sciences religieuses. 75(4). 578–578. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact